Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Oncology Pharma Inc (ONPH)

Oncology Pharma Inc (ONPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 4,080
  • Shares Outstanding, K 135,996
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta -2.25
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0250 +20.00%
on 10/25/19
0.0450 -33.33%
on 10/21/19
-0.0020 (-6.25%)
since 10/18/19
3-Month
0.0101 +197.03%
on 08/22/19
0.1000 -70.00%
on 08/30/19
+0.0021 (+7.53%)
since 08/19/19
52-Week
0.0030 +900.00%
on 06/18/19
0.1000 -70.00%
on 08/30/19
+0.0200 (+200.00%)
since 11/19/18

Most Recent Stories

More News
Patients Turn to Advanced Technology in Order to Combat Cancer

Over the past two decades, cancer-related deaths in the U.S. have declined significantly. As of 2015, the death rate for both men and women declined by 26% from its peak in 1991, according to the American...

ONPH : 0.0300 (+0.33%)
INO : 2.49 (+5.06%)
REGN : 347.01 (+0.74%)
AVEO : 0.64 (+1.59%)
SLS : 4.60 (+4.78%)
NWBO : 0.2110 (-1.17%)
Oncology Pharma Appoints Dr. Vijay Mahant as the Chief Scientific Officer and Chief Operating Officer

via NEWMEDIAWIRE -- Oncology Pharma, Inc. is pleased to announce today that Vijay Mahant (M.S, Ph.D.) has been appointed as the Chief Scientific Officer (CSO) of Oncology Pharma and its Chief Operating...

DGX : 104.56 (+0.08%)
ONPH : 0.0300 (+0.33%)
Companies Turn to Advanced Therapies to Curb the Spread of Cancer

FinancialBuzz.com News Commentary

ADXS : 0.41 (+5.13%)
GERN : 1.38 (+6.15%)
SLS : 4.60 (+4.78%)
ONPH : 0.0300 (+0.33%)
Companies Turn to Advanced Therapies to Curb the Spread of Cancer

In 2019, the American Cancer Society projected 1.76 million new cancer cases diagnosed and the number of deaths to stand at 606,880 in the U.S. Overall, the alarming projection has caused concern within...

ONPH : 0.0300 (+0.33%)
KDMN : 4.15 (+0.24%)
ADXS : 0.41 (+5.13%)
SLS : 4.60 (+4.78%)
GERN : 1.38 (+6.15%)
Patients Turn to Assistance Programs for Aid in the Fight Against Chronic Diseases

With the advancement of the cancer therapy market, new forms of treatment are now being studied and manufactured. Additionally, demand is expected to keep growing for currently effective treatments. Not...

CRIS : 1.43 (+2.88%)
IMMU : 19.06 (+1.71%)
ZIOP : 4.67 (+0.65%)
ONPH : 0.0300 (+0.33%)
Biotechs Endeavour to Increase Access to Cancer Treatments

Cancer is the second leading cause of death globally and was responsible for approximately 9.6 million deaths in 2018, according to the World Health Organization (WHO). Statistically, cancer is the cause...

ONPH : 0.0300 (+0.33%)
AGEN : 4.41 (+1.15%)
INO : 2.49 (+5.06%)
GERN : 1.38 (+6.15%)
ACST : 2.09 (-7.93%)
Technological Advancements Aid Medical Practitioners in Combatting Cancer

In 2018, there was an estimated 1.73 million new cancer cases diagnosed and 609,640 cancer deaths in the U.S., according to the American Cancer Society. The ACS does not expect cancer rates to slow down...

ONPH : 0.0300 (+0.33%)
UEEC : 1.3500 (+6.30%)
AVEO : 0.64 (+1.59%)
APVO : 0.62 (+3.33%)
SLS : 4.60 (+4.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

See More Share

Trade ONPH with:

Key Turning Points

2nd Resistance Point 0.0302
1st Resistance Point 0.0301
Last Price 0.0300
1st Support Level 0.0298
2nd Support Level 0.0296

See More

52-Week High 0.1000
Fibonacci 61.8% 0.0629
Fibonacci 50% 0.0515
Fibonacci 38.2% 0.0401
Last Price 0.0300
52-Week Low 0.0030

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar